Fleming
  1. Companies
  2. Fleming
  3. Events
  4. Sustainable Strategies for Generics & ...

Sustainable Strategies for Generics & Biosimilars

SHARE

This unique training covers a systematic evaluation and understanding of sustainable portfolio strategies, regulatory landscape, risk reduction and creating new market segments within generics and biosimilars industry.

Most popular related searches
Event Type:
Workshops/Training Courses
Date:
Mar. 6-7, 2017
Location:
Basel
  • Regulatory differences in the EU, US & regions of interest
  • Sustainable product portfolio for generics & biosimilars
  • Cost containment and procurement of generics & biosimilars
  • Redesign & optimization of generics & biosimilar model
  • Supergenerics vs generics

  • Generic business development & risk reduction

  • Creating new market segments

  • Generics in 2020 and beyond

  • Challenges of drug low prices and low margins

  • Health policy implications and recent evolutions

  • Approval pathways and registration issues

  • Expanding role of the OTC market as an INN defense

  • Interactive way of lecturing

    through stimulation of discussions

  • Individual case by case consultancy with the trainers

  • Comprehensive printed and digital

    course documentation

  • 8H+ of networking

    with other industry experts

  • Case studies from the trainer`s

    experience

  • Certificate of Completion

    issued by the trainers

BY POSITION

  • Product portfolio managers
  • Business developers
  • Strategic planners
  • Heads of R&D
  • Regulatory affairs
  • Market access
  • M&A
  • Intellectual property
  • Pricing & reimbursement

BY INDUSTRY

Pharmaceutical

  • Generics
  • Biosimilars
  • Healthcare